NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Company watch back to previous page show list
TAKEDA Pharmaceutical Company »01/04/2007 [Company watch]
China Biopharma forms distribution agreement with Takeda

China biopharma announced today that its Chinese subsidiary, Hainan CITIC Biopharmaceutical Development Co., Ltd., has entered into a distribution agreement with Takeda Pharmaceutical Company, Ltd. ("Takeda"), the largest pharmaceutical company in Japan. As part of Takeda's goal to expand sales channels in Asia, China Biopharma has begun distributing Serrapeptase tablets, and the agreement with Takeda calls for China Biopharma to distribute additional drugs as they become available.

 

China Biopharma, Inc. (BULLETIN BOARD: CBPC) , a biopharmaceutical company, announced today that its Chinese subsidiary, Hainan CITIC Biopharmaceutical Development Co., Ltd., has entered into a distribution agreement with Takeda Pharmaceutical Company, Ltd. ("Takeda"), the largest pharmaceutical company in Japan. With world headquarters located in Oska, Japan, Takeda specializes in the research and development of breakthrough drugs, and has marketing operations throughout U.S., Europe, and Asia. In Japan, Takeda has also built a strong presence in the over-the-counter (OTC) drug market, in which it holds the second largest domestic share.

Takeda has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions. As part of Takeda's goal to expand sales channels in Asia, China Biopharma has begun distributing Serrapeptase tablets, and the agreement with Takeda calls for China Biopharma to distribute additional drugs as they become available.


Wang Qiumen, General Manager of Hainan CITIC Pharmaceutical, commented, "Takeda is an internationally-renowned pharmaceutical company that offers China Biopharma tremendous new growth opportunities. This agreement marks a new milestone in our product diversification strategy. We are focused on adding products that can create steady and robust revenue streams year-round, and that can more than offset seasonal product sales such as our flu vaccines. Pharmaceuticals represent a high-growth, lucrative market that can serve large populations throughout China, and we are very excited to enter this market in the present quarter."


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.